FL (Follicular Lymphoma),Lymphoma Axi-Cel: Cost-Effective Choice Over Mosun in Treatment Analysis Jun 11, 2024
Lymphoma,MCL (Mantle Cell Lymphoma) Advancing Therapeutic Solutions for MCL: Bridging the Gap Jun 06, 2024
FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Efficacy and Safety of IRR Combo in Untreated FL and MZL May 30, 2024
FL (Follicular Lymphoma),Lymphoma,MZL (Marginal Zone Lymphoma) Evaluating Imaging for Indolent Cutaneous B-cell Lymphomas May 24, 2024
FL (Follicular Lymphoma),Lymphoma Loncastuximab & Rituximab Combo: Effective in Rel/Ref FL May 08, 2024
Lymphoma,MZL (Marginal Zone Lymphoma) IRTA1 Positivity in PCMZL: Implications Beyond IgM Expression Apr 10, 2024